These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23673908)

  • 41. Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels.
    Khan A; Khan SR; Hobus J; Faucett J; Mehra V; Giller EL; Rudolph RL
    J Psychiatr Res; 2011 Nov; 45(11):1489-96. PubMed ID: 21752394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
    Sanches RF; de Lima Osório F; Dos Santos RG; Macedo LR; Maia-de-Oliveira JP; Wichert-Ana L; de Araujo DB; Riba J; Crippa JA; Hallak JE
    J Clin Psychopharmacol; 2016 Feb; 36(1):77-81. PubMed ID: 26650973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.
    Ghaleiha A; Davari H; Jahangard L; Haghighi M; Ahmadpanah M; Seifrabie MA; Bajoghli H; Holsboer-Trachsler E; Brand S
    Eur Arch Psychiatry Clin Neurosci; 2016 Dec; 266(8):695-702. PubMed ID: 26984349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Merza Mohammad TA; Merza Mohammad TA; Salman DM; Jaafar HM
    Pharmacopsychiatry; 2024 Jul; 57(4):205-214. PubMed ID: 38710206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
    Eyre HA; Eskin A; Nelson SF; St Cyr NM; Siddarth P; Baune BT; Lavretsky H
    Int J Geriatr Psychiatry; 2016 May; 31(5):510-7. PubMed ID: 26471432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial.
    Zandifar A; Panahi M; Badrfam R; Qorbani M
    BMC Psychiatry; 2024 Feb; 24(1):163. PubMed ID: 38408937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression.
    Heresco-Levy U; Gelfin G; Bloch B; Levin R; Edelman S; Javitt DC; Kremer I
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):501-6. PubMed ID: 23174090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ropinirole Augmentation for Depression: A Randomized Controlled Trial Pilot Study.
    Gershon AA; Amiaz R; Shem-David H; Grunhaus L
    J Clin Psychopharmacol; 2019; 39(1):78-81. PubMed ID: 30489382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lithium Augmentation Versus Citalopram Combination in Imipramine-Resistant Major Depression: A 10-Week Randomized Open-Label Study.
    Navarro V; Boulahfa I; Obach A; Jerez D; Diaz-Ricart M; Gastó C; Guarch J
    J Clin Psychopharmacol; 2019; 39(3):254-257. PubMed ID: 30925498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early changes in prefrontal activity characterize clinical responders to antidepressants.
    Cook IA; Leuchter AF; Morgan M; Witte E; Stubbeman WF; Abrams M; Rosenberg S; Uijtdehaage SH
    Neuropsychopharmacology; 2002 Jul; 27(1):120-31. PubMed ID: 12062912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Curcumin as an add-on to antidepressive treatment.
    Pae CU
    Clin Neuropharmacol; 2013; 36(6):242-3. PubMed ID: 24201236
    [No Abstract]   [Full Text] [Related]  

  • 54. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.
    Al-Karawi D; Al Mamoori DA; Tayyar Y
    Phytother Res; 2016 Feb; 30(2):175-83. PubMed ID: 26610378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.
    Panahi Y; Badeli R; Karami GR; Sahebkar A
    Phytother Res; 2015 Jan; 29(1):17-21. PubMed ID: 25091591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.
    Asadi S; Gholami MS; Siassi F; Qorbani M; Sotoudeh G
    Phytother Res; 2020 Apr; 34(4):896-903. PubMed ID: 31788880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot dose-finding clinical trial of creatine monohydrate augmentation to SSRIs/SNRIs/NASA antidepressant treatment in major depression.
    Nemets B; Levine J
    Int Clin Psychopharmacol; 2013 May; 28(3):127-33. PubMed ID: 23466591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
    Amr M; El-Mogy A; Shams T; Vieira K; Lakhan SE
    Nutr J; 2013 Mar; 12():31. PubMed ID: 23510529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression.
    Feighner JP; Ehrensing RH; Kastin AJ; Patel A; Sverdlov L; Hlavka J; Abajian HB; Noble JF; Nicolau G
    Int Clin Psychopharmacol; 2001 Nov; 16(6):345-52. PubMed ID: 11712623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal oxytocin as an adjunct to escitalopram in major depression.
    Scantamburlo G; Ansseau M; Geenen V; Legros JJ
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E5. PubMed ID: 21677229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.